Franklin M Berger Rain Therapeutics Inc. (RAIN) insider trading activity

Franklin M Berger is Director of Rain Therapeutics Inc.. Currently has a direct ownership of 0 shares of RAIN, which is worth approximately $0. The most recent transaction as insider was on Jan 26, 2024, when has been sold 1,005,207 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

FRANKLIN M BERGER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 26 2024	SELL Disposition due to a tender of shares in a change of control transaction	-	1,005,207 Reduced 100.0%	0 Common Stock, par valu...
Nov 22 2022	BUY Open market or private purchase	$636,790 $8.27 p/Share	77,000 Added 7.12%	1,005,207 Common Stock
Nov 21 2022	BUY Open market or private purchase	$351,000 $7.8 p/Share	45,000 Added 4.62%	928,207 Common Stock
Nov 08 2022	BUY Open market or private purchase	$249,996 $5.83 p/Share	42,881 Added 4.63%	883,207 Common Stock
Sep 21 2021	BUY Open market or private purchase	$54,140 $14.3 p/Share	3,786 Added 0.45%	840,326 Common Stock
Apr 27 2021	BUY Conversion of derivative security	-	711,540 Added 45.96%	836,540 Common Stock
Apr 23 2021	BUY Open market or private purchase	$2,048,750 $16.39 p/Share	125,000 Added 50.0%	125,000 Common Stock

Also insider at

AVIR

Atea Pharmaceuticals, Inc. Healthcare

EPIX

ESSA Pharma Inc. Healthcare

FPRX

FIVE PRIME THERAPEUTICS, INC.

Director

BCEL

Atreca, Inc. Healthcare

Director

KZR

Kezar Life Sciences, Inc. Healthcare

FMB